FDA commissioner explains what he says 2002 Women’s Health Initiative study got wrong.mp4

FDA Commissioner Dr. Marty Makary makes an announcement about his agency’s intent to remove the “black box” warnings from hormone replacement therapy for menopause. FDA Commissioner Dr. Marty Makary makes an announcement about his agency’s intent to remove the “black box” warnings from hormone replacement therapy for menopause.